Navigation Links
Screening helps prevent cervical cancer in older women

New research from Queen Mary University of London reveals women over the age of 50 who don't attend cervical screening are four times more likely to be diagnosed with cervical cancer in later life.

The study, published today PLoS Medicine and funded by Cancer Research UK, underlines the importance of screening women over 50 for cervical cancer to prevent the disease, and provides the evidence that women with normal screening results between 50- 64 have a lower risk of cervical cancer into their eighties.

Researchers examined data taken from 1,341 women who were screened aged 50 to 64 and the number of cervical cancers diagnosed between 65 to 83. They included nearly all 65 to 83-year old women in England and Wales diagnosed with cervical cancer between 2007 and 2012.

Women who had not been screened after 50 had a six fold higher risk of being diagnosed with cervical cancer than those who had been screened but had a normal result during this time with 49 cancers being diagnosed per 10,000 unscreened women over 20 years, compared to eight cancers per 10,000 women with normal screening results.

Women who had been screened regularly but had a positive (abnormal) screening result between 50 and 64 had a risk of 86 per 10,000 women over 20 years.

The results suggest that cervical screening in women aged 50-64 has a substantial impact on cervical cancer rates not only at this age, but for many years after. The level of protection provided by having normal screening results declines over time, but even into their eighties women had a lower risk of cervical cancer compared to those who were not screened.

Peter Sasieni, Professor of Biostatistics & Cancer Epidemiology at Queen Mary University of London, Barts and The London School of Medicine and Dentistry, comments:

"Screening up to the age of 65 greatly reduces the risk of cervical cancer in the following decade, but the protection weakens with time and is substantially weaker 15 years after the last screen. With life expectancy increasing, it's important for countries that stop screening under age 60 to look into their screening programmes to maximise the number of cervical cancer cases prevented and the number of cervical cancers caught at an early stage."

The researched showed screening was equally effective for those women who were screened every five years compared to those screened every three years.

In England and Northern Ireland, women between the ages of 25 and 64 are invited for screening. Between the ages of 25 and 49 women are screened every three years. Between 50 and 64 years women have screening every five years.

In Scotland, women between 20 and 60 years are invited for screening every three years. Scotland will also extend screening for women up to the age of 64 from 2015.

In Wales, women between 20 and 64 are screened every three years.

Jessica Kirby, Cancer Research UK's senior health information manager, comments:

"These results provide reassurance that there is a real benefit to women over 50 having cervical cancer screening. Screening can pick up abnormal cells in the cervix that could develop into cervical cancer if left alone removing these cells prevents cancer from developing. Screening is a great way of reducing the risk of cervical cancer, and saves up to 5,000 lives a year in the UK. We encourage women to take up cervical screening when invited."


Contact: Charli Scouller
Queen Mary, University of London

Related medicine news :

1. Regenstrief and IU review finds lack of delirium screening in the emergency department
2. Increased risk of prostate cancer in African-American men; implications for PSA screening
3. PreCheck, Inc. Offers Human Resources Background Screening Training Webinar
4. Innovative Screening Strategy Swiftly Uncovers New Drug Candidates, New Biology
5. How Can University Educators Help Children's Vision? Katie Johnson Works with Graduate Students in Interactive Media and Design to Develop Vision Screening Tool
6. USAFact’s New RapidFACT Screening Platform Will Launch with Multiple Website Facelifts Tied to Both Old and New Products
7. New screening strategy to prevent cardiovascular complications in sports
8. Probability of Lung Cancer Overdiagnosis with LDCT Screening Addressed Using NLST Data
9. Computer model suggests genetic breast cancer screening may benefit those at intermediate risk
10. Super Bowl Champions Support Living Heart Foundation HOPE Program Screening and Pro Player Health Alliance Awareness Event In New York
11. The importance of standardizing drug screening studies
Post Your Comments:
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... , ... November 27, 2015 , ... Lizzie’s Lice Pickers ... company is offering customers 10% off of their purchase of lice treatment product. In ... full price. According to a company spokesperson. “Finding lice is a sure way to ...
(Date:11/27/2015)... ... ... No.1 Herpes-only dating community in the world, revealed that over 50% of its members are ... people under the age of 50 – or 67% of the population - are infected ... HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by Hollywood legend, ... that are presently affecting Americans. Dedicated to providing the world with a wide variety ... consumers focus on, one episode at a time. , In the latest installment ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma ... planned investment of at least $15.8  Million to ... Wilmington, NC . The expansion will ... to meet the growing demands of the pharmaceutical ... site expansion will provide up to 40,000 ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Henry Schein, ... and services to office-based dental, medical and animal health ... (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion , ... broadest array of open solutions designed to help any ... Click here for a schedule of experts ...
Breaking Medicine Technology: